Current Protocols in Toxicology
Online ISBN: 9780471140856
Your Author's Agreement letter specifies whether you are writing a protocol-style unit or a commentary unit. Complete instructions for preparing your contribution can be found in the Style Guide for Contributors. Close adherence to the Style Guide will minimize the need for extensive revisions later on and will ensure the quick and timely publication of your contribution.
If you have questions about any of the format requirements, please contact the Developmental Editor (Aditi Nadkarni, email@example.com). Questions regarding the scope and content of the contribution can be addressed by the appropriate Editor. See the Style Guide for complete contact information for the Editors.
A sample unit from CPTX is available for your reference (CPTX UNIT 6.3: Measurement of Glutathione Transport). If you need to see additional units in order to complete your contribution, please contact the Developmental Editor (Aditi Nadkarni).
Manuscript submission. Manuscripts should be submitted solely to Current Protocols and may not have been published, or be under consideration for publication, in any substantial form in another publication of any type. If there is a related paper under consideration at another publication, a copy of that paper should be submitted with the primary manuscript as supporting information. No material published in Current Protocols may be reproduced or published elsewhere without the written permission of the publisher. (See our copyright policy below). If any portions of your contribution (figures, tables) have been published previously, you must obtain permission to use that material in Current Protocols. Use the Copyright Permission Form or visit the original publisher's web site in order to secure permission, which should then be forwarded to Current Protocols.
Contributions to Current Protocols are generally invited by the editorial board. If you have a suggestion for a topic, or would like to submit a protocol, please contact the Developmental Editor (Aditi Nadkarni).
Manuscript review process. For thirty years, Current Protocols has set the standard for excellence in laboratory methods in the biological sciences. Every article undergoes a rigorous, multi-tiered review process that has been carefully optimized for protocol-based manuscripts. The process begins with our distinguished editorial board members, who carefully consider potential new content and the best authors prior to invitation. Unsolicited manuscripts or proposals for manuscripts are also subject to this vetting process. All manuscripts are extensively edited to our exacting standards by no less than three reviewers, each editing with a unique perspective and for a particular purpose. Every manuscript is subject to expert peer review by members of our editorial board. Guest editors or outside reviewers may be called upon if needed, but experience in evaluating laboratory protocols is essential. The next layer of review is performed by an in-house editor with an advanced degree in a relevant subject. Representing the perspective of the audience – i.e., a novice to the technique – this editor is trained to anticipate and address the questions that may arise when performing a protocol. This reviewer also considers thoroughness, presentation, clarity, and consistency with respect to the rest of the protocol collection. Based on these reviews, authors may be asked to revise a protocol prior to acceptance. The final editor, also a scientist with laboratory experience, then reviews the accepted manuscript in fine detail, requesting missing information, resolving any inconsistencies among protocol steps, and ensuring that every portion of the manuscript is complete so that each protocol works the first time, every time. Together, our editorial team works in close collaboration with the author to ensure that the final protocol is of the highest quality.
Authorship. In most cases, authors are invited to contribute specific methods to Current Protocols. Should an invited author wish to include co-authors, he or she should contact the developmental editor. Co-authors should only be added if they bring additional expertise or are co-inventors of the method. All authors should have made substantial contributions to the work and all must read and approve the final version to be published. Contributors who are not authors may be noted in an (optional) Acknowledgements section.
Human and animal subjects. If submitted protocols use animal or human subjects, authors must include a note in the protocol introduction that all experiments must be approved by the appropriate institutional and or national review boards and, in addition, that human subjects must give informed consent.
Conflict of interest. Authors are responsible for disclosing all financial and personal relationships between themselves and others that might bias their work. Authors should describe the role of sponsor(s), if any, in protocol design and in the collection, analysis and interpretation of data. If the supporting source had no such involvement, the authors should so state.
To prevent ambiguity, any possible conflict of interest, financial or otherwise, related to the submitted protocol must be clearly indicated in the manuscript or in a cover letter accompanying the submission.
Guidelines on Biosecurity Issues. Current Protocols is dedicated to the responsible publishing of protocols to further advance scientific knowledge and its application for the benefit of human life. Acknowledging that some experiments and microorganisms can be considered to have “dual use”—i.e., in which technology can be used legitimately for human betterment or misused for bioterrorism—the Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology (headed by Gerald Fink and part of the National Research Council, Division on Policy and Global Affairs) has identified seven classes of experiments that warrant special review by experts. Based on these recommendations, it is the policy of the editorial boards of Current Protocols NOT to publish protocols that describe in detail experiments that:
- render human or animal vaccines ineffective;
- confer resistance to therapeutically useful antibiotics or antiviral agents for humans, animals, or crops;
- enhance the virulence of human, animal, or plant pathogens, or make nonpathogens virulent;
- increase the transmissibility of pathogens;
- alter the host range of pathogens;
- enable the evasion of diagnostic or detection methods; or
- enable the weaponization of biological agents or toxins.
If you are unsure as to the appropriateness of your protocol for inclusion in Current Protocols, please contact the Developmental Editor (Aditi Nadkarni) to discuss prior to submission.
Copyright policy. The Article, including all figures, illustrations, and tabular and other supplementary material, shall be considered a work made for hire for Current Protocols, and we shall own the copyright and all of the rights comprised in the copyright. If the Article or any such material does not qualify as a work made for hire, then you hereby transfer to us during the full term of the copyright and all extensions thereof the full and exclusive rights comprised in the copyright and all other rights in and to the Article, and in any such material, in all media, worldwide.
You may draw on and refer to material in the Article in preparing other articles for publication in scholarly and professional journals and papers for delivery at professional meetings. In the event that the Article is not published, our liability to you shall be limited to return of the manuscript as soon as practicable after a decision has been made not to publish the Article. Upon such return, all rights to the Article shall be transferred to you.
You may not post and distribute your protocol on your own unprotected website.
An Article prepared by a U.S. federal government employee as part of the employee’s official duties, or which is part of an official U.S. Government publication, is called a "U.S. Government work," and is in the public domain in the United States. (Please see author agreement for further details.)
Wiley-Blackwell will support our authors by posting the accepted version of articles by NIH grant-holders to PubMed Central upon acceptance by Current Protocols. The accepted version is the version that incorporates all amendments made during peer review, but prior to the publisher's copy-editing and typesetting. This accepted version will be made publicly available 12 months after publication. The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008. Please see http://www.wiley.com/go/nihmandate for details. The foregoing applies to NIH grantees, not NIH employees. For NIH employees only, we will accept the NIH Publishing Agreement.
If the Article is to be written by you in the course of your employment, then your company/employer must also sign this Agreement.
Signed author agreements should be sent to our main editorial offices:
Current Protocols Editorial Office
Attn. Alexandra Cury
John Wiley and Sons, Inc.
111 River Street, MSC 8-02
Hoboken, New Jersey 07030